Skip to content
Bamboo WorksBamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Immunotech Biopharm

The provider of digital diagnostics and therapies has linked up with Chinese hospitals to detect conditions such as Alzheimer’s and brain trauma, but the business has yet to turn a profit.

IPO pitch puts BrainAurora’s earnings under the microscope

The provider of digital diagnostics and therapies has linked up with Chinese hospitals to detect conditions such as Alzheimer’s and brain trauma, but the business has yet to turn a…
November 14, 2024

Recent Articles

The provider of digital diagnostics and therapies has linked up with Chinese hospitals to detect conditions such as Alzheimer’s and brain trauma, but the business has yet to turn a profit.
November 14, 2024

IPO pitch puts BrainAurora’s earnings under the microscope

RECENT ARTICLES

  1. TYK Medicines
    March 20, 2025
    A blockbuster cancer drug? TYK’s claims go under the microscope
    2410.HK
  2. January 8, 2025
    BRIEF: BrainAurora opens flat in Hong Kong trading debut
    6681.HK
  3. December 11, 2024
    Why aim small? 51World Digital Twin sets its sights on cloning Earth
  4. February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
  5. March 27, 2025
    CARsgen seeks cell therapy breakthrough but stays in the red for now
    2171.HK
  6. December 24, 2024
    Shanghai Able’s renewed IPO plan hobbled by weak appetite for new tech listings
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.